News Results for Benchmark Holdings PLC (BMK)

Septima Maguire, Financial Director, bought 20,000 shares in the company on the 27th November 2020 at a price of £0.54. The Director now holds 284,914 shares. Story provided by...

Peter George, Chairman, bought 8,500 shares in the company on the 30th November 2020 at a price of £0.55. The Director now holds 3,055,719 shares. Story provided by StockMarketWire.com Director...

Peter George, Chairman, bought 46,000 shares in the company on the 30th November 2020 at a price of £0.55. The Director now holds 3,047,219 shares. Story provided by StockMarketWire.com Director...

Benchmark reported narrower annual losses following a good performance in its genetics business in the final quarter of the year from the previous year. For the 12 months ended 30 September...

Trond Williksen, Chief Executive Officer, bought 180,000 shares in the company on the 3rd September 2020 at a price of 0.460000p. The Director now holds 180,000 shares. Story provided by...

UK stocks drifted lower on a particularly quiet Friday for company news after Japanese markets were hit by reports that Prime Minister Shinzo Abe will resign for health reasons. At 0822, the...

Aquaculture health, nutrition and genetics business Benchmark reported narrower third-quarter losses, underpinned by higher revenue and margins in its genetics business. For the 3 months ended 30...

Aquaculture genetics, health and specialist nutrition business Benchmark said it had completed the sale of Improve International for up to £12.75m. Improve International, a global provider of...

Nutrition business Benchmark reported wider half-yearly losses as weak shrimp markets and rising competition dented performance in its advanced nutrition business. For the six months ended 31...

Aquaculture genetics and nutrition company Benchmark said it had appointed Trond Williksen as chief executive with effect from 1 June 2020. Most recently, Williksen was CEO of SalMar ASA, the...

Septima Maguire, Financial Director, bought 14,914 shares in the company on the 13th March 2020 at a price of 33.52p. The Director now holds 264,914 shares. Story provided by StockMarketWire.com...

Peter George, Chairman, bought 58,000 shares in the company on the 5th March 2020 at a price of 34.93p. The Director now holds 2,401,219 shares. Story provided by StockMarketWire.com Director...

Peter George, Chairman, bought 25,000 shares in the company on the 4th March 2020 at a price of 35.00p. The Director now holds 2,343,219 shares. Story provided by StockMarketWire.com Director...

Food producer Benchmark Holdings wider losses in the first quarter of the year on lower revenue amid weak shrimp and Mediterranean seabass and bream markets. For 2019, pre-tax losses widened to...

Septima Maguire, Financial Director, 250,000 shares in the company on the 19th February 2020 at a price of 40.00p. The Director now holds 250,000 shares. Story provided by StockMarketWire.com...

Susan Searle, Non Executive Director, 100,000 shares in the company on the 19th February 2020 at a price of 40.00p. The Director now holds 198,125 shares. Story provided by StockMarketWire.com...

Hugo Wahnish, Non Executive Director, 75,000 shares in the company on the 19th February 2020 at a price of 40.00p. The Director now holds 350,000 shares. Story provided by StockMarketWire.com...

Yngve Myhre, Non Executive Director, 200,000 shares in the company on the 19th February 2020 at a price of 40.00p. The Director now holds 600,000 shares. Story provided by StockMarketWire.com...

Kevin Quinn, Non Executive Director, 25,000 shares in the company on the 19th February 2020 at a price of 40.00p. The Director now holds 85,929 shares. Story provided by StockMarketWire.com...

Alex Raeber, Executive Director, 7,658 shares in the company on the 19th February 2020 at a price of 40.00p. The Director now holds 207,658 shares. Story provided by StockMarketWire.com...

Peter George, Chairman, 1,318,219 shares in the company on the 21st February 2020 at a price of 40.00p. The Director now holds 2,318,219 shares. Story provided by StockMarketWire.com Director...

Benchmark said it had conditionally raised £36.4m though a discounted-equity placing and also said it intended to raise up to a further £6.6m through an open offer. Benchmark will issue up to...

Aquaculture health, nutrition and genetics business Benchmark booked a deeper annual loss after it wrote down the value of its assets. Net losses for the year through September amounted to £83.1m,...

Benchmark said Malcolm Pye had decided to retire from the board to pursue other opportunities after completing a successful handover of his executive responsibilities over the last three months....

Food-focused genetics business Benchmark said it expected lower annual earnings, as growth in its advanced nutrition division was hindered by adverse conditions in the shrimp, seabass and seabream...

Aquatic health company Benchmark said it had appointed Septima Maguire as chief financial officer with effect from 18 December 2019. Mark Plampin would remain CFO of the group until 18 December...

Benchmark said it was in line to receive $8.75m from AquaChile, representing the final payment following the agreement to dissolve their joint venture. Payment was due within five days of signing....

Alex Raeber, Executive Director, bought 200,000 shares in the company on the 10th October 2019 at a price of 43.50p. The Director now holds 200,000 shares. Story provided by StockMarketWire.com...

Yngve Myhre, Non Executive Director, bought 225,000 shares in the company on the 11th September 2019 at a price of 44.44p. The Director now holds 325,000 shares. Story provided by...

Yngve Myhre, Non Executive Director, bought 75,000 shares in the company on the 13th September 2019 at a price of 47.00p. The Director now holds 400,000 shares. Story provided by...

Peter George, Chairman, bought 1,000,000 shares in the company on the 13th September 2019 at a price of 47.00p. The Director now holds 1,000,000 shares. Story provided by StockMarketWire.com...

Benchmark, an aquaculture health, nutrition and genetics business, said its founder and chief executive officer, Malcolm Pye, would be stepping down to allow the company to appoint a new chief...

Healthcare and genetics company Benchmark said challenging conditions in the global shrimp, Mediterranean seabass and bream markets had continued to hurt sales volumes in advanced nutrition....

Aquaculture technology firm Benchmark Holdings posted a 3% increase in first half revenue to £78.3m despite challenging conditions in the global shrimp markets, with growth in Genetics, Health and...

Benchmark, the aquaculture health, nutrition and genetics business, said it had completed the dissolution of its joint venture with AquaChile. As previously announced, Benchmark said it would...

Healthcare company Benchmark said it had delivered a 'good performance' in the first half of the year as earnings increased by quarter. The company also said it was looking to refinance its...

Benchmark said it was talks with AquaChile to dissolve their joint venture as the company seeks to reinvest the funds to take control of the salmon breeding facility currently owned by the JV....

Health and nutrition business Benchmark said Thursday adjusted profits rose 19%, led by a jump in revenue from its genetics division. For the 12 months ended 31 December, adjusted profit, which...

Yngve Myhre, Non Executive Director, bought 100,000 shares in the company on the 10th December 2018 at a price of 57.50p. The Director now holds 100,000 shares. Story provided by...

Benchmark Holdings said Tuesday it had successfully defended a patent infringement in Asia. The IP&IT court in Thailand had ordered that MTI cease using the company's patented technology and...

Fish farming group Benchmark said it expected to post full-year adjusted earnings growth of more than 65%. Adjusted Ebitda for the year through September would be above £16.5m, as revenue grew by...

Register today and join Shares and AJ Bell Media at their investor evening event at at the Radisson Blu Hotel, Edinburgh, Royal Mile, as it provides an opportunity for Board Directors, from dynamic...

Hugo Wahnish, Non Executive Director, bought 100,000 shares in the company on the 9th October 2018 at a price of 56.50p. The Director now holds 275,000 shares. Story provided by...

Benchmark said Wednesday it had agreed to acquire Videntis AS, a provider of data technology to aquaculture and agriculture producers, for total of up to £0.30m. Videntis' technology enabled...

Benchmark Holdings, an aquaculture health, advanced nutrition and genetics business, confirmed Tuesday Chief Scientific Officer Dr Alex Raeber had joined the board and commenced his role at the...

Benchmark Holdings said it had started producing salmon eggs at its new £40m land-based breeding facility in Salten, Norway. The increased capacity would allow Benchmark to supply the global...

Benchmark Holdings said Monday Alex Raeber had been appointed as Chief Scientific Officer. Raeber is expected to commence his new role in early October, the company said. Alex has had a strong...

Numis today upgrades its investment rating on Benchmark Holdings Plc (LON:BMK) to buy (from add) and raised its price target to 92p (from 78p). Story provided by StockMarketWire.com Broker...

Aquaculture health business Benchmark swung to a profit in the year through March compared to the previous year as revenue grew 9%. For the six months ended 31 March 2018, adjusted profit before...

Nutrition and genetics business Benchmark Holdings said it had agreed to fund a Chilean salmon breeding joint venture with Empresas AquaChile and would raise £19m to help fund the deal. The...

Hugo Wahnish, Non Executive Director, bought 50,000 shares in the company on the 6th February 2018 at a price of 66.50p. The Director now holds 50,000 shares. Story provided by...

Kepler Cheuvreux today reaffirms its buy investment rating on Benchmark Holdings Plc (LON:BMK) and raised its price target to 77p (from 68p). Story provided by StockMarketWire.com

Kevin Quinn, Non Executive Director, bought 35,929 shares in the company on the 23rd January 2018 at a price of 69.55p. The Director now holds 60,929 shares. Story provided by...

Beaufort Securities today initiates coverage of Benchmark Holdings Plc (LON:BMK) with a speculative buy investment rating and price target of 80p. Story provided by StockMarketWire.com

Numis today downgrades its investment rating on Benchmark Holdings Plc (LON:BMK) to add (from buy) and left its price target at 78p. Story provided by StockMarketWire.com

Benchmark Holdings announced a loss of £7.1 million for the year ended 30 September 2017, despite reporting like-for-like revenues rose 13% to £140m during the year. The £7.1 million loss of the...

Numis today upgrades its investment rating on Benchmark Holdings Plc (LON:BMK) to buy (from add) and set its price target at 78p. Story provided by StockMarketWire.com

Benchmark, the aquaculture health, nutrition, and genetics business, has announced the results of its highly successful first commercial scale field trial of its next generation sea lice treatment...

Benchmark Holdings expects adjusted EBITDA for the 12 months to the end of September to be ahead of previous forecasts. The group said revenue of £138m was in line with market expectations but...

Benchmark, the aquaculture health, nutrition and breeding and genetics business, has developed specific pathogen resistant shrimp to address issues facing the Asian market, the largest and...

Benchmark Holdings has announced the appointment of Hugo Wahnish and Yngve Myhre as Non-Executive Directors of the Company with immediate effect. At 1:29pm: (LON:BMK) Benchmark Holdings Plc...

Benchmark, the aquaculture biotechnology and food chain sustainability business, has appointed Hugo Wahnish and Yngve Myhre as non-executive directors with immediate effect. Benchmark said...

Benchmark has announced that its new land-based salmon broodstock facility in Norway was now ready to house its first batch of broodstock. It said the 10,000 square-metre facility would receive...

Benchmark has announced that operations at its state-of-the-art vaccine antigen production facility in Braintree, Essex, began on 29 Sep. Benchmark said the £17m biotechnology building had...

Kepler Cheuvreux today upgrades its investment rating on Benchmark Holdings Plc (LON:BMK) to buy (from hold) and cut its price target to 68p (from 74p). Story provided by StockMarketWire.com

The UK's largest pub retailer Greene King (GNK) was the biggest mid-cap faller this morning. Its share price fell 11.2% to 584.9p after like-for-like sales declined 1.2% in the 18 weeks to 3...

It was bad news from the UK's largest pub retailer Greene King (GNK) after its like-for-like sales fell 1.2% in the first 18 weeks of its financial year compared to a market decline of 0.7%. The...

Benchmark, the aquaculture biotechnology and food chain sustainability business, expects revenues to be in line with market forecasts, and adjusted EBITDA to be in the range £8.7m to £9.3m, for the...

Story provided by StockMarketWire.com

Benchmark's wholly owned subsidiary, INVE Aquaculture Holding BV, has successfully renewed its sales and marketing agreement with the Great Salt Lake Brine Shrimp Cooperative. Benchmark said...

Kepler Cheuvreux today downgrades its investment rating on Benchmark Holdings Plc (LON:BMK) to hold (from buy) and cut its price target to 74p (from 98p). Story provided by StockMarketWire.com

Operating losses at Benchmark, the aquaculture biotechnology and food chain sustainability business, narrowed to £6.7m in the six months to the end of March - down from £15.2m last time. Revenues...

Story provided by StockMarketWire.com

Benchmark said its performance for the six months to 31 March was broadly in line with the board's expectations. Benchmark said during the period it signed a joint venture agreement with SalMar...

Story provided by StockMarketWire.com

Alex Hambro, Chairman, bought 53,125 shares in the company on the 26th April 2017 at a price of 90.00p. The Director now holds 100,000 shares. Story provided by StockMarketWire.com Director...

Benchmark Holdings has announced that, at the Company's Annual General Meeting held today, all resolutions were duly passed. At 2:30pm: (LON:BMK) Benchmark Holdings Plc Ord 0.1p share price was...

Benchmark has signed a long-term agreement with SalMar ASA to provide genetics, health and knowledge services to the company. Benchmark said the full suite of services was providing illustrated...

Kevin Quinn, Non Executive Director, bought 25,000 shares in the company on the 15th February 2017 at a price of 94.04p. The Director now holds 25,000 shares representing 0.00% of the shares in...

Numis today reaffirms its add investment rating on Benchmark Holdings Plc Ord 0.1p (LON:BMK) and set its price target at 102p. Story provided by StockMarketWire.com

Benchmark, the aquaculture biotechnology and food chain sustainability business, saw revenues rise to £109.4m in the year to the end of September, up from £44.2m in 2015. Earnings before interest,...

Story provided by StockMarketWire.com

Numis today initiates coverage of Benchmark Holdings Plc Ord 0.1p (LON:BMK) with a add investment rating and price target of 89p. Story provided by StockMarketWire.com

Mark Plampin, Financial Director, exercised 135,000 shares in the company on the 1st December 2016 at a price of 0.10p. The Director now holds 536,686 shares. Story provided by...

Benchmark, the aquaculture biotechnology and food chain sustainability business, expects its performance for the year ended 30 September to be in line with the board's forecasts. Benchmark says...

Story provided by StockMarketWire.com

Benchmark's animal health division has entered into an agreement with Evax AG, a Swiss equine biotech company, to develop a recombinant vaccine to prevent and treat the most prevalent skin disease...

Story provided by StockMarketWire.com

Benchmark Holdings has entered into a technology transfer agreement under which its wholly-owned subsidiary, Genetica Spring SAS, will secure control over aquaculture breeding programmes...

Story provided by StockMarketWire.com

Benchmark, the international biotechnology and food chain sustainability business, has announced a 47,279,127 new ordinary shares at 65p apiece to raise approximately £30.7m, gross. The placing...

Story provided by StockMarketWire.com

Benchmark (BMK) announced one of its new generation aquaculture vaccines has been released into the market for commercial field trials. The vaccine is the first in a series of Benchmark's new...

Benchmark has announced that a subsidiary of its breeding & genetics division SalmoBreed AS has signed a ten-year agreement with Lerøy Aakvik Roe and Stamfisk AS - one of the world's top three...

Story provided by StockMarketWire.com

First half revenues at Benchmark, the international biotechnology and food chain sustainability business, rose by by 142% to £48.0m with the bulk of the growth (£20.6m) arising from three months...

Story provided by StockMarketWire.com

Berenberg today initiates coverage of Benchmark Holdings Plc Ord 0.1p (LON:BMK) with a buy investment rating and price target of 70p. Story provided by StockMarketWire.com

Benchmark, the biotechnology and food chain sustainability business, says its performance for the six months to 31 March was in line with management's expectations. The integration of INVE is...